The staphylococcal toxins γ-haemolysin AB and CB differentially target phagocytes by employing specific chemokine receptors
Evasion of the host phagocyte response by Staphylococcus aureus is crucial to successful infection with the pathogen. γ-haemolysin AB and CB (HlgAB, HlgCB) are bicomponent pore-forming toxins present in almost all human S. aureus isolates. Cellular tropism and contribution of the toxins to S. aureus...
Gespeichert in:
Veröffentlicht in: | Nature communications 2014-11, Vol.5 (1), p.5438, Article 5438 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Evasion of the host phagocyte response by
Staphylococcus aureus
is crucial to successful infection with the pathogen. γ-haemolysin AB and CB (HlgAB, HlgCB) are bicomponent pore-forming toxins present in almost all human
S. aureus
isolates. Cellular tropism and contribution of the toxins to
S. aureus
pathophysiology are poorly understood. Here we identify the chemokine receptors CXCR1, CXCR2 and CCR2 as targets for HlgAB, and the complement receptors C5aR and C5L2 as targets for HlgCB. The receptor expression patterns allow the toxins to efficiently and differentially target phagocytic cells. Murine neutrophils are resistant to HlgAB and HlgCB. CCR2 is the sole murine receptor orthologue compatible with γ-haemolysin. In a murine peritonitis model, HlgAB contributes to
S. aureus
bacteremia in a CCR2-dependent manner. HlgAB-mediated targeting of CCR2
+
cells highlights the involvement of inflammatory macrophages during
S. aureus
infection. Functional quantification identifies HlgAB and HlgCB as major secreted staphylococcal leukocidins.
Genes encoding two pore-forming toxins (γ-haemolysins HlgAB and HlgCB) are present in almost all human
Staphylococcus aureus
isolates. Here Spaan
et al.
show that HlgAB and HlgCB target different phagocyte types by interacting with specific chemokine receptors and complement receptors, respectively. |
---|---|
ISSN: | 2041-1723 2041-1723 |
DOI: | 10.1038/ncomms6438 |